Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Hangzhou AGS MedTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,068	1,031	1,955	213.38	204.53	155.7
Short-Term Investments	-	81.2	-	-	-	-
Trading Asset Securities	662.92	671.22	82.42	55.01	1.09	-
Cash & Short-Term Investments	1,731	1,784	2,037	268.4	205.62	155.7
Cash Growth	-14.16%	-12.44%	659.01%	30.53%	32.06%	12.19%
Accounts Receivable	49.02	48.15	58.51	18.83	12.24	12
Other Receivables	1.16	0.79	1.18	2.11	2.04	2.03
Receivables	50.18	48.95	59.68	20.95	14.28	14.04
Inventory	60.92	56.38	46.8	38.57	39.89	20.01
Prepaid Expenses	-	-	0.05	0.1	-	0.18
Other Current Assets	61.78	5.42	2.45	3.88	2.78	3.2
Total Current Assets	1,904	1,894	2,146	331.89	262.56	193.12
Property, Plant & Equipment	196.66	200.09	159.7	117.67	54.89	41.32
Long-Term Investments	432.43	432.43	-	-	-	-
Other Intangible Assets	18.11	18.27	19	19.72	19.95	20.77
Long-Term Deferred Tax Assets	1.11	1.24	1.9	0.36	0.3	0.25
Long-Term Deferred Charges	3.87	2.77	2.35	3.3	3.18	3.64
Other Long-Term Assets	0.83	0.58	1.99	0.19	1.12	1.32
Total Assets	2,557	2,550	2,331	473.13	341.99	260.41
Accounts Payable	51.4	66.02	48.41	32.05	37.65	23.94
Accrued Expenses	14.2	40.84	34.79	24.29	9.13	11.57
Current Portion of Leases	1.31	1.3	0.57	1.08	0.94	-
Current Income Taxes Payable	13.41	17.49	14.95	15.7	6.95	1.67
Current Unearned Revenue	10.48	8.28	5.14	7.15	8.77	4.53
Other Current Liabilities	1.65	8.05	16.88	10.76	5.56	1.84
Total Current Liabilities	92.45	141.99	120.73	91.03	69	43.55
Long-Term Leases	1.82	2.15	-	0.57	1.39	-
Long-Term Unearned Revenue	8.3	8.53	2.1	-	-	0.17
Long-Term Deferred Tax Liabilities	-	-	-	-	0.16	-
Total Liabilities	102.56	152.67	122.83	91.59	70.55	43.72
Common Stock	80.98	80.98	57.87	43.4	43.4	43.4
Additional Paid-In Capital	1,726	1,725	1,715	76.53	76.53	76.53
Retained Earnings	678.12	621.87	434.79	261.54	151.62	96.82
Treasury Stock	-31	-30.97	-	-	-	-
Comprehensive Income & Other	0.19	0.1	0.11	0.07	-0.1	-0.06
Shareholders' Equity	2,454	2,397	2,208	381.54	271.45	216.69
Total Liabilities & Equity	2,557	2,550	2,331	473.13	341.99	260.41
Total Debt	3.13	3.45	0.57	1.64	2.32	-
Net Cash (Debt)	1,728	1,780	2,037	266.75	203.3	155.7
Net Cash Growth	-14.29%	-12.59%	663.48%	31.21%	30.57%	12.19%
Net Cash Per Share	21.42	22.09	28.06	4.39	3.35	2.56
Filing Date Shares Outstanding	81.52	80.58	81.02	60.76	60.76	60.76
Total Common Shares Outstanding	81.52	80.58	81.02	60.76	60.76	60.76
Working Capital	1,811	1,752	2,025	240.86	193.57	149.57
Book Value Per Share	30.10	29.75	27.26	6.28	4.47	3.57
Tangible Book Value	2,436	2,379	2,189	361.82	251.5	195.93
Tangible Book Value Per Share	29.88	29.52	27.02	5.95	4.14	3.22
Buildings	-	164.61	71.12	26.84	26.84	26.84
Machinery	-	52.19	41.56	7.7	28.88	20.29
Construction In Progress	-	8.65	67.92	72.65	10.55	4.63

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.